Ignite Creation Date:
2025-12-24 @ 9:56 PM
Ignite Modification Date:
2025-12-31 @ 12:13 PM
Study NCT ID:
NCT01030432
Status:
COMPLETED
Last Update Posted:
2015-10-09
First Post:
2009-12-10
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of BMS-650032 With Peginterferon Alfa-2a Plus Ribavirin
Sponsor:
Bristol-Myers Squibb
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2010-02
Start Date Type:
None
Primary Completion Date:
2012-10
Primary Completion Date Type:
ACTUAL
Completion Date:
2012-10
Completion Date Type:
ACTUAL
First Submit Date:
2009-12-10
First Submit QC Date:
None
Study First Post Date:
2009-12-11
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2015-10-09
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2015-09-23
Last Update Post Date:
2015-10-09
Last Update Post Date Type:
ESTIMATED